Bookmark

Add to MyYahoo RSS

Advanced Transit Dynamics News

News on Advanced Transit Dynamics (Ticker: JNJ) continually updated from thousands of sources around the net.

5 hrs ago | Seeking Alpha

Johnson & Johnson: Moving To Higher-Growth Technologies, Capitalizes On Renewed Profitability

The company is selling less profitable business units to make room for higher growth medical technologies that can drive margins and earnings up.

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, VisionCare Ophthalmic Technologies, Startups, Johnson Controls

Fri Aug 29, 2014

Federal Computer Week

President nominates Deyo to DHS management slot

The White House plans to nominate Russell C. Deyo to fill the Department of Homeland Security's undersecretary for management position left vacant when Raphael Borras departed this past winter.

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, VisionCare Ophthalmic Technologies, Startups, Johnson Controls

Thu Aug 28, 2014

Reuters

Johnson & Johnson to seek buyer for medical device maker unit -WSJ

Johnson & Johnson plans to seek a buyer for its medical device maker business, Cordis Corp, The Wall Street Journal reported citing people familiar with the matter.

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, OrthoClinical Diagnostics, Medical Equipment, Healthcare Industry, VisionCare Ophthalmic Technologies, Startups

BioSpace

Wellness & Prevention Showcases Johnson & Johnson Official 7 Minute...

Parks Associates announced today that executives from Wellness & Prevention, Inc., a Johnson & Johnson company, will participate in the session "Population Health Management: Tracking Technology's Impact" and host a special workout session to showcase the updated Johnson & Johnson Official 7 Minute Workout App during the 2014 Connected Health ... (more)

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, VisionCare Ophthalmic Technologies, Startups, LOC-AID Technologies

TheStreet.com

Why Johnson & Johnson (JNJ) Stock Is Declining Today

Your browser is not supported. Please upgrade to one of the following browsers: Google Chrome Mozilla Firefox Apple Safari Microsoft Internet Explorer 8+ You may proceed to the site by clicking here , however some pages might not work correctly.

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, VisionCare Ophthalmic Technologies, Startups, Johnson Controls

Wed Aug 27, 2014

Bloomberg

IBM's Jeopardy-Playing Watson Becomes Science Researcher

International Business Machines Corp. wants you to know that its Watson technology can do more than win "Jeopardy!" -- it can now help accelerate scientific research and discoveries.

Comment?

Related Topix: IBM, Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, VisionCare Ophthalmic Technologies, Startups

Mon Aug 25, 2014

Seeking Alpha

Johnson & Johnson: High Profitability, Trading Below Fair Value

Johnson & Johnson is one of the biggest healthcare companies in the world, with revenues of $74 billion and earnings of $15.6 billion in the last twelve months.

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, Aria Systems, VisionCare Ophthalmic Technologies, Startups

Pharmaceutical Processing

Cilag GmbH International Acquires Covagen AG

Cilag GmbH International, an affiliate of the Janssen Pharmaceutical Companies of Johnson & Johnson, announced today that it has acquired Covagen AG, a privately-held, biopharmaceutical company specializing in the development of multispecific protein therapeutics through the FynomAb technology platform.

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, VisionCare Ophthalmic Technologies, Startups, Johnson Controls

Sun Aug 17, 2014

IMedia Connection

5 brands that climbed out of reputation hell

For a brand, recovering its reputation after a crisis can be a complicated business.

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, VisionCare Ophthalmic Technologies, Startups, Johnson Controls

Fri Aug 15, 2014

BioSpace

National Institute for Clinical Excellence (NICE) And Johnson & Johnson Urged To End Zytiga Fiasco

Patient groups and academics have urged the National Institute for Health and Care Excellence and Johnson & Johnson unit Janssen to get back to the table following the former's rejection of Zytiga as a treatment for prostate cancer before chemotherapy.

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, VisionCare Ophthalmic Technologies, Startups, Johnson Controls

Thu Aug 14, 2014

Seeking Alpha

Johnson & Johnson: Don't Miss The Pullback Opportunity

JNJ can comfortably grow its dividend per share by 6%-7% per annum over the next few years with both free cash flow and earnings payout levels being steady.

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, VisionCare Ophthalmic Technologies, Startups, Johnson Controls

Fri Aug 08, 2014

Sys-Con Media

Anapol Schwartz Law Firm Accepting Morcellation Cancer Cases

Women and their families are urged to contact the firm immediately to protect their legal rights and discuss filing a morcellator cancer lawsuit .

Comment?

Related Topix: Healthcare Law, Law, Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, Food, J and J Snack Foods

Seeking Alpha

Johnson & Johnson: Where Did The Bears Go? I Will Stand Alone.

Johnson & Johnson has had a nice climb in price over the last several years. The company has strong operating margins, low interest expenses, and a solid return on equity.

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, Aria Systems, VisionCare Ophthalmic Technologies, Startups

Thu Aug 07, 2014

Seeking Alpha

Johnson & Johnson's Power Morcellator Recall Could Result In Further Pullback

Johnson & Johnson recently withdrew three laparoscopic power morcellators due to a risk of spreading cancerous tissue, following FDA's warning in April.

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, VisionCare Ophthalmic Technologies, Startups, Johnson Controls

Daily Kos

Dear Johnson & Johnson: Pay for Your Mistakes

Johnson & Johnson grabbed headlines this week for withdrawing from the market power morcellators, manufactured by subsidiary Ethicon, citing " uncertainty " about the "risk-benefit assessment" associated with the device's use.

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, Aria Systems, VisionCare Ophthalmic Technologies, Startups

Adweek

UM Gets a New U.S. President

Insider Kasha Cacy today succeeds Sarah Personette as U.S. president, as Personette exits following maternity leave to become the head of global business marketing at Facebook.

Comment?

Related Topix: Marketing, Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, VisionCare Ophthalmic Technologies, Startups

Tue Aug 05, 2014

Seeking Alpha

Johnson & Johnson: A Quality Dividend Company At Attractive Valuation

Johnson & Johnson is a dividend king which has paid dividends since 1944 and has managed to increase them for 52 years in a row.

Comment?

Related Topix: Johnson & Johnson, Biotech, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, VisionCare Ophthalmic Technologies, Startups, Johnson Controls

Mon Aug 04, 2014

Reuters

COLUMN-Healthcare: A remedy for long-term investors

The fastest-growing segment of the global population is aged 60 and over, according to the United Nations Department of Economic and Social Affairs.

Comment?

Related Topix: Biotech, Science / Technology, Johnson & Johnson, Johnson and Johnson, Medicine, Johnson and Johnson Merck Consumer Pharmaceuticals, Healthcare Industry, Pfizer

•••
•••
•••
•••
•••

Ashburn Jobs

•••
•••
•••
•••